Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2009
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258437 Compounds and methods for rapid labeling of n-glycans
10/15/2009US20090257969 Soft anticholinergic zwitterions
10/15/2009CA2720613A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
10/14/2009EP2044076B1 Process for the preparation of asenapine and intermediate products used in said process.
10/14/2009CN101555222A New preparation method of intermediate product of barnidipine hydrochloride
10/14/2009CN100549012C Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors
10/14/2009CN100549003C 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/14/2009CN100548978C Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
10/14/2009CN100548386C Releasable polymeric conjugates based on biodegradable linkers
10/14/2009CN100548291C MCH antagonists for the treatment of obesity
10/13/2009US7601868 Such as 4-(cyclopropylmethoxy)-N-(2-{4-[1-(1-pyrrolidinyl)ethyl]phenyl}ethyl)benzamide having melanin-concentrating hormone antagonistic action, for prophylaxis and/or treatment of obesity
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601742 Pyrrolidones with anti-HIV activity
10/13/2009US7601708 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals
10/13/2009US7601706 Bile-acid conjugates providing for sustained systemic concentration of drugs
10/13/2009US7601675 Acid ammonium salts of an imide of polymaleic anhydride; hydraulic fracturing fluids used in enhanced oil recovery; subterranean formations
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/13/2009CA2429844C Mch antagonists and their use in the treatment of obesity
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009122997A1 Method of producing (s)-3-(1-cyano-1,1-diphenylmethyl)-pyrrolidine
10/08/2009WO2009121989A1 Method for obtaining polysubstituted pyrrolidines with hepatitis c inhibiting activity
10/08/2009WO2009094569A3 Method for the enzymatic kinetic resolution of acyloxyalkyl thiocarbonates used for the synthesis of acyloxyalkyl carbamates
10/08/2009US20090253917 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylates, process for production of the same, and use of the same
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253703 Organic compounds
10/08/2009US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders
10/08/2009US20090253672 Cathepsin Cysteine Protease Inhibitors
10/08/2009US20090253670 nicotinic receptor modulators such as N-[3-(1H-pyrrol-1-yl)benzyl]-4-[(trifluoromethyl)thio]benzamide, useful for treating and preventing a condition or disorder affecting cognition, neurodegeneration and schizophrenia
10/08/2009US20090253669 Substituted Sulfonamide Compounds
10/08/2009US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009DE102009016750A1 Farbstoffverbindung Dye compound
10/08/2009CA2720038A1 Novel donor-acceptor fluorene scaffolds: a process and uses thereof
10/07/2009EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/07/2009EP0741700B1 1-h-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents
10/07/2009CN101550100A Method for preparing Levetiracetam
10/07/2009CN101550099A Method for preparing Levetiracetam
10/06/2009US7598400 AMPO spin traps
10/06/2009US7598395 Heterocyclocarboxamide derivatives
10/06/2009US7598386 Sulphones which modulate the action of gamma-secretase
10/06/2009US7598358 Transferring electric charging; coloring; ion permselective films used for display; comprises transition metal (for example, silver ion) as central atom, and basic ligands comprised of 5-membered heterocyclic aromatic compound (for example, pyrrole rings), in which position of central atom can be changed
10/06/2009US7598274 Pyrrole derivatives
10/06/2009US7598250 for treating neurodegenerative disease such as Alzheimer's disease
10/06/2009US7598235 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals
10/06/2009CA2368095C Process for preparing inhibitors of nucleoside metabolism
10/01/2009WO2009119858A1 Benzene compound, and use thereof for medical purposes
10/01/2009WO2009118712A2 Novel dihydroxypyrrolidine derivatives as anti-cancer agents
10/01/2009WO2009118473A2 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
10/01/2009WO2009118305A1 Hydroxamate-based inhibitors of deacetylases b
10/01/2009WO2009118292A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009WO2009117829A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
10/01/2009US20090247770 Process for making lactam tachykinin receptor antagonists
10/01/2009US20090247769 Colorant
10/01/2009US20090247731 Boronic ester and acid compounds, synthesis and uses
10/01/2009US20090247547 Hydroxamate-based inhibitors of deacetylases b
10/01/2009US20090247513 Benzothiophene compounds having antiinfective activity
10/01/2009US20090247506 Antibacterial agents
10/01/2009US20090247474 3-Aminopyrrolidine Derivatives As Modulators Of Chemokine Receptors
10/01/2009CA2756800A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
10/01/2009CA2719477A1 Hydroxamate-based inhibitors of deacetylases b
10/01/2009CA2719457A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009CA2716961A1 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
09/2009
09/30/2009EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses
09/30/2009EP2041082B1 Pyrrolidine derivatives having activity at the glyt1 transporter
09/30/2009EP1658066B1 Adamantylglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes
09/30/2009EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
09/30/2009EP1389305B1 Peptide fragmentation
09/30/2009CN101544606A Malononitrile compound and use thereof
09/30/2009CN101544588A Method for preparing carbobenzoxygroup- hydroxyproline-methyl ester
09/29/2009US7595407 Boron complexation strategy for use in manipulating 1-acyldipyrromethanes
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595344 Sulphones which modulate the action of gamma secretase
09/29/2009US7595314 Such as (2-morpholin-4-yl-5-nitro-phenyl)-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-methanone; for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease
09/29/2009US7595309 For therapy of bacterial infections and neoplasms,
09/29/2009CA2427812C Novel .beta.-lactam compounds and process for producing the same
09/29/2009CA2393793C Substituted group 4 metal complexes, catalysts and olefin polymerization process
09/29/2009CA2318208C Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
09/29/2009CA2255171C 1,3,8-triaza-spiro[4,5]decan-4-on derivatives
09/24/2009WO2009117465A1 Substituted gamma lactams as prostaglandin ep2 agonists
09/24/2009WO2009115257A1 Substituted sulfonamide derivatives
09/24/2009WO2009114950A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
09/24/2009US20090240066 Intermediates for the production of optically active cyclopropylamine derivatives and process for the production of the intermediates
09/24/2009US20090240065 Black color material and toner
09/24/2009US20090240064 Crystalline form of atorvastatin hemi-calcium
09/24/2009US20090239929 N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors
09/24/2009US20090239928 N-Pyrrolidin-3YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors
09/24/2009US20090239919 Glutamate receptor modulators and therapeutic agents
09/24/2009US20090239911 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
09/24/2009US20090239910 Benzenesulfonamide Compounds and Their Use
09/24/2009US20090239885 Inhibitors of nucleoside phoshorylases and nucleosidases
09/24/2009US20090239867 1-(2,4-Dimethoxybenzyl)-5-oxo-pyrrolidine-3-carboxylic Acid Methyl Ester; for treating inflammatory bowel disease, glaucoma or ocular hypertension, asthma or baldness; prostaglandin EP2 agonists
09/24/2009US20090239866 Peptide deformylase inhibitors
09/24/2009US20090239829 Thioaryl substituted inhibitors of zinc proteases and their use
09/24/2009CA2718959A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
09/24/2009CA2718736A1 Pyrrolidinyl derivatives and uses thereof
09/24/2009CA2718551A1 Substituted sulfonamide derivatives
09/23/2009EP2103623A2 Novel macrocyclic inhibitors of Hepatitis C virus replication
09/23/2009EP2103603A1 Method for producing pyrrolidine compound
09/23/2009EP2102157A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 404